Cargando…
Efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis
BACKGROUND: The efficacy of selective serotonin reuptake inhibitors (SSRIs) in the treatment of acute COVID-19 is still under investigation, with conflicting results reported from randomized controlled trials (RCTs). Different dosing regimens may have contributed to the contradictory findings. OBJEC...
Autores principales: | Deng, Jiawen, Rayner, Daniel, Ramaraju, Harikrishnaa B., Abbas, Umaima, Garcia, Cristian, Heybati, Kiyan, Zhou, Fangwen, Huang, Emma, Park, Ye-Jean, Moskalyk, Myron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841740/ https://www.ncbi.nlm.nih.gov/pubmed/36657488 http://dx.doi.org/10.1016/j.cmi.2023.01.010 |
Ejemplares similares
-
Efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: author's response
por: Deng, Jiawen, et al.
Publicado: (2023) -
Differential efficacy and safety of anti-SARS-CoV-2 antibody therapies for the management of COVID-19: a systematic review and network meta-analysis
por: Deng, Jiawen, et al.
Publicado: (2022) -
Efficacy of chloroquine and hydroxychloroquine for the treatment of hospitalized COVID-19 patients: a meta-analysis
por: Deng, Jiawen, et al.
Publicado: (2021) -
Efficacy of lopinavir–ritonavir combination therapy for the treatment of hospitalized COVID-19 patients: a meta-analysis
por: Deng, Jiawen, et al.
Publicado: (2022) -
Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
por: Compagner, Chad, et al.
Publicado: (2021)